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Abstract: Madangamines are a group of bioactive marine sponge 
alkaloids, embodying an unprecedented diazapentacyclic skeletal 
type. The enantioselective total synthesis of madangamine D has 
been accomplished, which represents the first total synthesis of an 
alkaloid of the madangamine group. It involves the stereoselective 
construction of the diazatricyclic ABC core using a phenylglycinol-
derived lactam as the starting enantiomeric scaffold and the 
subsequent assembly of the peripheral macrocyclic rings. The 
synthesis provides for the first time a pure sample of madangamine 
D and confirms the absolute configuration of this alkaloid family. 
 
Sponges in the order Haplosclerida have proven to be a rich source 
of structurally diverse but biogenetically related alkaloids,[1] most of 
them displaying significant biological activities. These marine 
alkaloids   comprise   a  great   variety   of   unusual   skeletal  types, 
 
Figure 1. Alkaloids of the madangamine group. 
including an array of complex polycyclic diamine structures bearing 
macrocyclic rings, such as saraines, ingenamines, manzamines, 
nakadomarin A, and madangamines.[2] Madangamines are one of the 
least studied of these alkaloids from the synthetic standpoint, [3] and 
no total synthesis on this series has been reported so far. [4] The first 
isolation of an alkaloid of this group, madangamine A, was reported 
by Andersen in 1994[5] from the marine sponge Xestospongia ingens, 
collected in Papua New Guinea. A few years later the same team 
described[6] four new related alkaloids, madangamines BE,[7] from 
the same organism, and more recently, Berlinck reported the 
isolation of madangamine F from the Brazilian sponge 
Pachychalina alcaloidifera.[8] Madangamines A and F have shown 
significant in vitro cytotoxicity against a number of tumor cell lines. 
However, no bioactivity data have been reported for madangamines 
BE, and further pharmacological research on this alkaloid group 
has been thwarted by the minute amounts of alkaloid samples 
available from natural sources.  
Structurally, madangamines are pentacyclic alkaloids with an 
unprecedented skeletal type, characterized by a diazatricyclic core 
(ABC rings) bearing three contiguous stereogenic centers, one of 
them quaternary, and  two linear carbon bridges  that connect N-7 to 
 
Figure 2. Synthetic strategy. 
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C-9 (D ring) and N-1 to C-3 (E ring). The peripheral macrocyclic 
ring D is different in each madangamine, in size as well as in degree 
and position of unsaturation, whereas ring E is identical in 
madangamines AE but different in madangamine F, which also 
incorporates a C-4 hydroxy group (Figure 1).  
We present herein the enantioselective synthesis of ()-
madangamine D, which provides for the first time a pure sample[7] 
of this natural product and constitutes the first total synthesis of an 
alkaloid of the madangamine group. Using a phenylglycinol-derived 
bicyclic lactam[9] as the starting enantiomeric scaffold,[10] our 
approach involves the initial construction of the bridged 
diazatricyclic ABC core common to all madangamines,[11] and the 
subsequent building of the macrocyclic D and E rings (Figure 2). 
The starting enantiopure lactam 2 was easily accessible[12] by 
cyclocondensation of oxoester 1 with (R)-phenylglycinol, in a 
process that installs the first stereocenter (C-5 in the madangamine 
numbering)[13] by dynamic kinetic resolution of the racemic 
substrate. The key functionalized diazatricyclic intermediates would 
be  prepared   from   an   unsaturated   lactam   derived   from   2,  by  
successive construction of the carbocyclic C and piperidine A rings. 
Crucial stereochemical issues are the generation of the required B/C 
cis ring junction, by a stereoselective conjugate addition reaction 
followed by a ring-closing metathesis process, and the control of the 
C-9 stereochemistry in the alkylation step. Finally, the assembly of 
the macrocyclic rings would be accomplished by a ring-closing 
metathesis reaction (ring D) and a Wittig olefination followed by 
macrolactamization (ring E). 
The overall synthetic sequence is shown in Scheme 1. Lactam 2 was 
converted in excellent overall yield to unsaturated lactam 3, via an 
epimeric mixture of intermediate seleno derivatives. A 
stereoselective, stereoelectronically controlled,[14] conjugate addition 
of an allyl residue led to the cis-diallyl substituted lactam 4, from 
which the carbocyclic C ring was constructed by a ring-closing 
metathesis reaction to give the cis-octahydroisoquinolone derivative 
5. A stereoselective alkylation from the most accessible face of the 
-keto ester moiety of 5 generated the quaternary C-9 stereocenter 
in 6 and installed a C-9 functionalized carbon chain. At this point, 
the removal  of  the  phenylethanol  moiety  from the chiral auxiliary 
 
Scheme 1. Enantioselective synthesis of madangamine D. Reagents and conditions: a) LiHMDS, (Boc)2O, then C6H5SeCl, THF,78 ºC, 93%; b) H2O2, CH2Cl2, rt, 2 
h; c) CH2=CHCH2MgBr, CuI, LiCl, TMSCl, THF, 78 ºC, 20 h, 82% (from the seleno derivative); d) Grubbs 2nd gen., CH2Cl2, rt, 18 h, 80%; e) NaH, 
(CH2O)2CH(CH2)3Br, TBAI, DMF, rt, 18 h, 90%; f) Na/liq. NH3, –33 ºC, 2 min; then LiAlH4, dioxane, reflux, 20 h; then (Boc)2O, CH2Cl2, rt, 4 h, 45%; g) Et3N, MsCl, 
CH2Cl2, rt, 4 h; h) NaN3, DMF, 90 ºC, 48 h, 79% (from 7); i) m-CPBA, CH2Cl2, rt, 5 h; j) Me3P, THF, 1 h; then H2O, rt, 20 h; k) p-TsCl, Et3N, CH2Cl2, 0 ºC, 2.5 h, 60% 
(from 8); l) NaH, BnBr, TBAI, DMF, 0.05 M, rt, 20 h, 80%; m) TFA, CH2Cl2, rt, 30 min; then ClCO(CH2)5CH=CH2, Et3N, CH2Cl2, 0 ºC, 3 h; then rt, 18 h, 92%; n) HCl, 
THF, rt, 2 h; then KOt-Bu, Br  Ph3P
+
CH3, THF, rt, 20 h, 80%; (o) Grubbs 1st gen., CH2Cl2, 0.2 mM, reflux, 12 h; p) H2, Pd/C, EtOH, rt, 24 h; then Dess–Martin, 
CH2Cl2, rt, 4 h, 75% (from 12); q) NaHMDS, Br
 (Z)-Ph3P
+
CH2CH2CH=CH(CH2)3CO2Me (15), THF, 0 to 60 °C, 70%; r) Na, naphtalene, THF, 78 °C; s) aq. LiOH, 
THF, then EDCI, HOBt, DMF/CH2Cl2, 0.02 M, rt, syringe pump, 75% (from 16); t) LiAlH4, THF, rt, 3 h, 68%. 
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was achieved by successive treatment of 6 with Na in liquid NH3, 
which caused the cleavage of the benzylic CN bond, and LiAlH4, 
which brought about the reduction of the resulting unstable -
oxylactam. Under the latter conditions, the lactam and ester 
carbonyl functions were also reduced to give an N-unsubstituted 
piperidine-3-methanol derivative, which was immediately protected 
as the N-Boc piperidine 7. In this way, the tert-butoxycarbonyl 
group not only has provided activation towards the conjugate 
addition step and allowed the stereoselective alkylation of the 1,3-
dicarbonyl intermediate 5, but is also the precursor of the 
aminomethyl chain required for the closure of the piperidine A ring. 
This was accomplished by a stereocontrolled cascade 
aminohydroxylation. To this end, once alcohol 7 was converted to 
azide 8 via a mesylate, and the cyclohexene double bond was 
epoxidized, a Staudinger reduction of azide 9 led to an intermediate 
amino epoxide, which underwent a smooth in situ cyclization. A 
subsequent protection of the resulting diazatricyclic alcohol led to 
the N-tosyl derivative 10. 
With the functionalized diazatricyclic derivative 10 in hand, the next 
phase of the synthesis was the construction of the western 14-
membered D ring.[15] After benzylation of the C-3 hydroxy group 
selective deprotection of N-7 in the resulting orthogonally protected 
diamino derivative, followed by acylation with 7-octenoyl chloride, 
led to tricyclic amide 11. Hydrolysis of the acetal function and 
Wittig methylenation of the resulting aldehyde gave the required 
dialkene derivative 12. A ring-closing metathesis reaction of 12 
under diluted conditions using the first generation Grubbs catalyst 
provided the expected tetracyclic alkene 13 (2:1 mixture of Z/E 
isomers). A subsequent catalytic hydrogenation, which caused both 
the reduction of the carbon-carbon double bond and the 
debenzylation of the benzyl ether protecting group, followed by 
Dess–Martin periodinane oxidation of the resulting alcohol led to 
ketone 14, which served as a platform to construct the eastern 11-
membered E ring.  
The (Z,Z)-unsaturated eight-carbon fragment required to complete 
the synthesis of madangamine D was incorporated in a 
straightforward manner by a Wittig reaction using the ylide 
generated from phosphonium salt 15[16] under strictly anhydrous 
conditions. Removal of the protecting tosyl substituent in the 
resulting diastereoisomeric mixture of alkenes 16 (2.2:1 Z/E 
ratio),[17] followed by hydrolysis of the ester function and 
macrolactamization, led to pentacyclic dilactam 17. A final LiAlH4 
reduction provided madangamine D. The 1H and 13C NMR data of 
our synthetic madangamine were coincident with those reported[6] 
for the natural product (see Tables in the Supporting Information). 
To date, the absolute configuration of madangamines has only been 
inferred by correlation with that of their presumed[1,2bd,3ab] 
biosynthetic precursors, ingenamines.[18] As our synthetic 
madangamine D, of unambiguous 2S, 5S, 9R, 12R absolute 
configuration, has a specific rotation {[]= + 101.3 (c 0.29, 
CHCl₃)} with the same sign as in the closely related madangamines 
AC,[19] our synthesis confirms the absolute configuration of this 
alkaloid family. 
Madangamine D showed significant in vitro cytotoxic activity 
against human colon HT29 (GI50 4.4 g/mL) and pancreas PSN1 
(GI50 7.4 g/mL) cancer cell lines, but was inactive against lung 
NSCLC A549 and breast MDA-MB-231 cancer cell lines at the 
highest assayed concentration (10 g/mL). 
Using appropriately C-9 substituted diazatricyclic derivatives, the 
strategy we have developed could be applied to the synthesis of 
other members of the madangamine group.[20] 
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The first total synthesis of an alkaloid of the madangamine group has been 
accomplished. Using a phenylglycinol-derived lactam as the starting enantiomeric 
scaffold, the synthesis of (+)-madangamine D involves the successive construction 
of the six-membered carbocyclic C and heterocyclic A rings to generate 
functionalized diazatricyclic ABC intermediates and the subsequent assembly of the 
peripheral macrocyclic D and E rings. 
 
 
